Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / oxycontin attending: chief complaint: 62 yo m w/ hemoptysis x 3 days major surgical or invasive procedure: bronchoscopy with placement of y-stent to trachea. argon plasma laser cautery of active bleeding. history of present illness: 62 year old m with history of scc lung s/p lul and partial lll lobectomy , no chemo or radiation who initially presented to with hemoptysis. patient states he had developed a cough and chest congestion w/o fevers. pcp prescribed around . then around or so, he noticed some blood in his sputum. this increased in amount until when his wife was concerned enough to bring him to southshore's er. ct showed a mass involving right lateral wall of proximal trachea pushing carina anteriorly. bronch at hospital showed blood in trachea and tumor on right lateral tracheal wall, compromising the terminal trachea and proximal main stem bronchi. biopsies were taken and bal gs showed few polys and rare gpc. post-bronch, his o2sats dropped to 70-80s in the setting of hemoptysis, prompting intubation and transfer to . past medical history: pmh: 1) squamous cell left lung ca dx , w/ left upper and partial lower lobectomy , no chemotherapy or radiation 2) dm2 3) htn 4) cad s/p four stents in 5) ibd social history: lives with wife. former . no etoh. family history: hx of disease, cad physical exam: vitals: t=98.5, bp=120s/80s, p=65, o2sat=100% on vent gen: intubated, sedated heent: perrl, edema around eyes, mm dry, no lad, no jvd cv: rrr, nl s1/s2 pulmo: coarse breath sounds b/l gi: bs+, nt, nd ext: warm, 2+ dp/pt neuro: responds to painful stimuli pertinent results: labs on arrival to 9pm: ph 7.38, pco2 45, po2 218, hco3 28, basexs 1 type:art; intubated; fio2%:60; rate:12/; tv:650; peep:8; temp:36.9 k:4.0 freeca:1.14 wbc 13.2, hct 36.7, plt 292, n:77.5 l:17.7 m:4.4 e:0.3 bas:0.1 pt: 12.2 ptt: 29.1 inr: 1.0 chest ct impression: 1. paratracheal and subcarinal masses within the mediastinum invading the mid thoracic trachea and distal trachea, carina and mainstem bronchi. there is marked narrowing of the tracheal and right and left main stem bronchial lumens due to invasion. findings favor secondary invasion of the airway from the mediastinal nodal masses rather than a primary airway neoplasm. 2. consolidation within the left lower lobe, likely representing aspiration, infection, or hemorrhage in the setting of hemoptysis. 3. status post left upper lobectomy and wedge resection of the left lower lobe. cxr : increased density involving the entire left hemithorax is suggestive of left pleural effusion. associated atelectatic changes are suspected in the left upper lobe and the left lower lobe. the right lung is clear. there is no evidence of pneumothorax. impression: increasing left pleural effusion. no evidence of pneumothorax. : fluoro-guided picc line placement: impression: successful placement of a 35 cm 4-french single lumen vaxcel picc in the right brachial vein. tip is in the svc. the line is ready for use. path from bronch bx: specimen submitted: tracheal tumor (perm) and (frozen) (3 jars). procedure date tissue received report date diagnosed by dr. /cma?????? diagnosis a. tracheal tumor 1: combined squamous cell-small cell carcinoma, invasive (see note). b. tracheal tumor 2: combined squamous cell-small cell carcinoma, invasive (see note). c. tracheal tumor 3: combined squamous cell-small cell carcinoma, invasive (see note). note: 1) immunostains for p63, chromogranin (focal), synaptophysin and ttf-1 are all positive in subsets of the tumor cells. 2) an in-situ squamous carcinoma/dysplasia is present suggesting a separate primary. 3) slides were reviewed with dr. . . clinical: none given. gross: the specimen is submitted in three parts. part 1 is: tracheal tumor. part 2 is: tracheal tumor. part 3 is: tracheal tumor. part 1 is received fresh in the o. r. and consists of multiple fragments of tan and red soft tissue aggregate measuring 1.4 x 1.2 x 0.3 cm. the specimen is entirely submitted for frozen sectioned, and frozen section diagnosis by dr. is: "carcinoma; foci of non-small cell carcinoma present; component of small round blue cells also present. (lymphoid cells vs. small cell component); final diagnosis pending permanent sections." the frozen section remnant is entirely submitted in a. part 2 is labeled "tracheal tumor" and consists of a 1.1 x 0.2 cm aggregate of clotted blood and pink tissue fragments. the specimen is entirely submitted b. part 3 is labeled "tracheal tumor" and consists of multiple small fragments of tan brown blackened tissue aggregating 1.0 x 1.0 x 0.5 cm, entirely submitted in c. 10:08 am bronchoalveolar lavage **final report ** gram stain (final ): 4+ (>10 per 1000x field): polymorphonuclear leukocytes. 2+ (1-5 per 1000x field): gram positive cocci. in pairs, chains, and clusters. respiratory culture (final ): 10,000-100,000 organisms/ml. oropharyngeal flora. staph aureus coag +. 10,000-100,000 organisms/ml.. oxacillin resistant staphylococci must be reported as also resistant to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. rifampin should not be used alone for therapy. . please contact the microbiology laboratory () immediately if sensitivity to clindamycin is required on this patient's isolate. sensitivities: mic expressed in mcg/ml _________________________________________________________ staph aureus coag + | erythromycin---------- =>8 r gentamicin------------ <=0.5 s levofloxacin---------- =>8 r oxacillin------------- =>4 r penicillin------------ =>0.5 r rifampin-------------- <=0.5 s tetracycline---------- <=1 s vancomycin------------ <=1 s urine cx no growth blood cx , ngtd blood cx negative brief hospital course: a/p: 65 y/o m w/ h/o cad, t2dm, htn, and squamous cell ca of left lung admitted to hospital w/ hemoptysis d/w lung ca s/p intubation for worsening hemoptysis/hypoxia, extubated and currently stable on 2 l nc w/o further hemoptysis. # hemoptysis: likely due to malignant mass. s/p argon laser tx to invading tumor . hct stable w/o transfusion since . hematocrit 28.1 on day of discharge. . # lung cancer: patient underwent bronchoscopy for bx/tx/dx and path c/w recurrent scc. chest ct was repeated here and shows a paratracheal and subcarinal mass invading the right and left mainstem bronchi. he had a y-tube stent placed to maintain patency of the airways. cea 4.0. thoracic surgery was consulted and deemed mr. not an operable candidate. medical oncology and radiation oncology consulted during this admission. plan for chemoradiation. patient wishes to do radiation treatments at . appointment made for him to see dr. . medical oncology here will be contacting patient with his appointment with them. he has been scheduled for an outpatient pet scan for staging. . # mrsa pneumonia: patient w/ hypoxia on presentation. extubated but w/ persistent o2 requirement. patient spiked while in house and was started on levofloxacin. he continued to spike on this antibiotic. subsequently, sputum cx from bal grew out mrsa. patient's interventional pulmonologist, dr. , saw the patient during his stay and attempted ultrasound thoracentesis of patient's left pleural effusion. there was not enough flood to permit a tap. he will f/u with mr. as an outpatient. blood cx from are negative and subsequent cx from and 11 are ngtd. plan for 14 days total of vancomycin + levofloxacin. picc placed by ir. patient discharged w/ prescription for home o2, in addition to guaifenesin. . # gi bleeding: patient had increasing diarrhea in the icu. he has a h/o ibd and states this has happened to him in the past. however, he also had an episode of bloody diarrhea (approximately 1 teaspoon). hct remained stable. no transfusions were necessargy. asa initially held but restarted without issues. plan for f/u w/ outpatient pcp to consider colonoscopy. patient d/c home on qd ppi. . # htn: home bp meds restarted following extubation and patient's bp has been well-controlled. . # t2dm: well-controlled blood sugars on home glyburide. . # cad: no c/o chest pain this admission. patient continued on his home asa, statin, bb, and ace. no chf on cxr/exam. . # crohn's: stools are loose. no antibx within past 3 months. continue asacol and azathioprine. . # ppx: sq heparin, ppi . # fen: ivfs (bun/creat>20), phos repleted this am, dm/cardiac diet . # full code . # access: central line in icu, d/c home w/ picc . # dispo: home w/ services (iv antibx, picc care, o2) medications on admission: --asacol 400 mg --nifedical 60 mg qd --azathioprine 25 mg --uniretic 15/12.5 qd --glyburide 10 mg qhs --coreg 18.75 mg --avandamet 4/500, 2 tabs daily --lipitor 40 mg qd --diovan 80 mg qhs --aspirin 162 mg qd discharge medications: 1. moexipril 15 mg tablet sig: one (1) tablet po daily (daily). 2. hydrochlorothiazide 25 mg tablet sig: 0.5 tablet po daily (daily). 3. valsartan 80 mg tablet sig: one (1) tablet po daily (daily). 4. levofloxacin 500 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 11 days. disp:*11 tablet(s)* refills:*0* 5. guaifenesin 600 mg tablet sustained release sig: two (2) tablet sustained release po bid () for 11 days. disp:*44 tablet sustained release(s)* refills:*0* 6. azathioprine 50 mg tablet sig: 0.5 tablet po bid (2 times a day). 7. atorvastatin calcium 40 mg tablet sig: one (1) tablet po daily (daily). 8. nifedipine 60 mg tablet sustained release sig: one (1) tablet sustained release po daily (daily). 9. glyburide 5 mg tablet sig: two (2) tablet po daily (daily). 10. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 11. vancomycin in dextrose 1 g/200 ml piggyback sig: one (1) gram intravenous q 12h (every 12 hours) for 25 doses. disp:*25 gram* refills:*0* 12. picc line care per protocol 13. bun, creatinine please check in 1 week and call to dr. , 14. oxygen 2l continuous home o2 15. carvedilol 6.25 mg tablet sig: three (3) tablet po twice a day. discharge disposition: home with service facility: home therapies discharge diagnosis: primary diagnoses: non-small cell lung cancer secondary diagnoses: mrsa pneumonia gastrointestinal bleeding discharge condition: desaturations to 86% with ambualtion on room air. no coughing of blood. no gross blood in stool. discharge instructions: please call your doctor or go to the emergency room if you have recurrent blood in your sputum, blood in your stool, worsening shortness of breath, or temperature greater than 101. followup instructions: you have a pet scan scheduled at the hospital, nuclear medicine, on wednesday, , at 1210. do not eat or drink anything besides water for 6 hours prior to the appointment, no strenuous exercise, or sugary food for 24 hours. you have an appointment with your primary care physician, . on tuesday at 1200. you have an appointment to see dr. at to discuss radiation therapy of your lung cancer on at 10:30 am. address: cancer center, , exit 5. phone: ( your medical oncologist and pulmonologist will contact you regarding appointments. please call your gastroenterologist, dr. at medical clinic in for follow-up of your bloody bowel movement while in the hospital. procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified fiber-optic bronchoscopy fiber-optic bronchoscopy fiber-optic bronchoscopy other bronchoscopy other intubation of respiratory tract endoscopic excision or destruction of lesion or tissue of bronchus diagnoses: pure hypercholesterolemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) infection with microorganisms resistant to penicillins aortocoronary bypass status regional enteritis of unspecified site acute respiratory failure methicillin susceptible pneumonia due to staphylococcus aureus hemorrhage of gastrointestinal tract, unspecified irritable bowel syndrome malignant neoplasm of main bronchus 

Answer: The patient is high likely exposed to